Dyadic to Present at Brean Murray Investor Conference

Dyadic International, Inc. (AMEX:DIL), a biotechnology
company engaged in the development, manufacture and sale of biological
products, announced today that its President and CEO, Mark Emalfarb,
will present at the Brean Murray Carret & Co. Small Cap Institutional
Investor Conference, to be held on January 31st - February 1, 2006 at
The Grand Hyatt Hotel in New York City. The presentation will take
place at 2:30 PM EST on Wednesday, February 1, 2006 and will be
webcast live. An archive of the webcast will be available for 30 days.
To access the live webcast or archived presentation, please go to
http://www.dyadic-group.com.

   About Dyadic

   Dyadic International, Inc., is engaged in the development,
manufacture and sale of proteins, enzymes and other bio-molecules, as
well as the licensing of its enabling proprietary technology to
collaborators for the discovery, development and manufacture of
biological products from genes. Dyadic markets its products and
services for applications in the textile, chemical, agricultural, pulp
& paper, pharmaceutical, biotechnology and other industries, using its
proprietary C1 Host Technology and C1 Expression and Screening Systems
for the discovery, development and production of biological products.

   Cautionary Statement for Forward-Looking Statements

   Certain statements contained in this press release are
"forward-looking statements." These forward-looking statements involve
risks and uncertainties that could cause our actual results,
performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of charge
on the SEC's web site at http://www.sec.gov, including our Annual
Report on Form 10-KSB for the year ended December 31, 2004, and our
Quarterly Report on Form 10-QSB for the quarter ended September 30,
2005. Except as required by law, we expressly disclaim any intent or
obligation to update any forward-looking statements.